Han, K., Baker, M., Patel, P., Margolis, D., Spreen, W., Moore, K. P., & Ford, S. L. (2019). 1532. Population Pharmacokinetic (PPK) Modeling and Simulation of Long-Acting (LA) Cabotegravir (CAB) to Inform Strategies Following Dosing Interruptions in HIV-1-Infected Subjects. Open Forum Infect Dis.
Citação norma ChicagoHan, Kelong, Mark Baker, Parul Patel, David Margolis, William Spreen, Katy P. Moore, and Susan L. Ford. "1532. Population Pharmacokinetic (PPK) Modeling and Simulation of Long-Acting (LA) Cabotegravir (CAB) to Inform Strategies Following Dosing Interruptions in HIV-1-Infected Subjects." Open Forum Infect Dis 2019.
Citação norma MLAHan, Kelong, et al. "1532. Population Pharmacokinetic (PPK) Modeling and Simulation of Long-Acting (LA) Cabotegravir (CAB) to Inform Strategies Following Dosing Interruptions in HIV-1-Infected Subjects." Open Forum Infect Dis 2019.